Lanean...
GLP-1 receptor agonists: a review of head-to-head clinical studies
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while having a low risk of hypoglycemia. The GLP-1 RA class has grown in the last decade with several agents available for use in the U...
Gorde:
| Argitaratua izan da: | Ther Adv Endocrinol Metab |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321870/ https://ncbi.nlm.nih.gov/pubmed/25678953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018814559725 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|